SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides oral cancer drug plant gets European nod

04 Jul 2011 Evaluate

Strides Arcolab Ltd’s tablets and capsules facility in its oncology medicine complex had received European regulatory approval. It expected to take two products to Europe during the July-September third quarter this year. The oral dosages facility is part of Onco Therapies Ltd, the cancer drugs arm under Strides subsidiary, Agila Specialities. OTL's injectables facility is already approved by major regulatory agencies, enabling Strides to sell its products in many overseas markets. In Europe, it has made 18 filings for oncology products that have potential local sales of $3.2 billion.crackcrack

Strides Pharma Scien Share Price

1155.90 0.05 (0.00%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×